Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 20/20 | 0.67 |
| ▸ | CDK2 | P24941 | 20/20 | 0.67 |
| ▸ | CCNE2 | O96020 | 10/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4688173 | 1.00 | CCNE1 (0.67) | CCNE1CDK2CCNE2 | |
| SCHEMBL7819721 | 0.87 | CCNE1 (0.62) | CCNE1CDK2CCNE2 | |
| SCHEMBL7819725 | 0.87 | CCNE1 (0.62) | CCNE1CDK2CCNE2 | |
| SCHEMBL7819720 | 0.85 | CCNE1 (0.59) | CCNE1CDK2CCNE2 | |
| SCHEMBL7819722 | 0.85 | CCNE1 (0.59) | CCNE1CDK2CCNE2 | |
| SCHEMBL14289941 | 0.83 | PDPK1 (0.56) | CCNE1CDK2CCNE2 | |
| SCHEMBL7830190 | 0.82 | CCNE1 (0.55) | CCNE1CDK2CCNE2 | |
| SCHEMBL6977943 | 0.82 | CCNE2 (0.64) | CCNE1CDK2CCNE2 | |
| SCHEMBL6977953 | 0.82 | CCNE2 (0.64) | CCNE1CDK2CCNE2 | |
| SCHEMBL7830189 | 0.82 | CCNE1 (0.55) | CCNE1CDK2CCNE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1149106-B1 | 4,5-AZOLO-OXINDOLES | HOFFMANN LA ROCHE (CH) | 2003-03-19 | — | — | EP | claimed |
| EP-1149106-A2 | 4,5-AZOLO-OXINDOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-31 | — | — | EP | claimed |
| WO-2000035920-A2 | 4,5-AZOLO-OXINDOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | claimed |
| EP-1149105-B1 | 4,5-PYRAZINOXINDOLES AS PROTEIN KINASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2008-02-27 | — | — | EP | disclosed |
| EP-1149105-B1 | 4,5-PYRAZINOXINDOLES AS PROTEIN KINASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2008-02-27 | — | — | EP | disclosed |
| EP-1149106-B1 | 4,5-AZOLO-OXINDOLES | HOFFMANN LA ROCHE (CH) | 2003-03-19 | — | — | EP | disclosed |
| EP-1149105-A1 | 4,5-PYRAZINOXINDOLES AS PROTEIN KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-31 | — | — | EP | disclosed |
| EP-1149106-A2 | 4,5-AZOLO-OXINDOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-31 | — | — | EP | disclosed |
| US-6221867-B1 | TREATING RHEUMATOID ARTHRITIS | HOFFMANN-LA ROCHE INC. | 2001-04-24 | — | — | US | disclosed |
| US-6197804-B1 | KINASE INHIBITORS; ANTICANCER AGENTS | HOFFMANN-LA ROCHE INC. | 2001-03-06 | — | — | US | disclosed |
| US-6153634-A | FOR THERAPY AND PROPHYLAXIS OF CANCER TUMORS; INHIBITOR OFCYCLIN-DEPENDENT KINASES (CDKS) | HOFFMANN-LA ROCHE INC. (US) | 2000-11-28 | — | — | US | disclosed |
| WO-2000035921-A1 | 4,5-PYRAZINOXINDOLES AS PROTEIN KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035920-A2 | 4,5-AZOLO-OXINDOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-06-22 | — | — | WO | disclosed |